BACKGROUND: Despite the burden of depression, there remain few data on its economic consequences in an international context. AIMS: To explore the relationship between depression status (with and without medical comorbidity), work loss and health care costs, using cross-sectional data from a multi-national study of depression in primary care. METHOD: Primary care attendees were screened for depression. Those meeting eligibility criteria were categorised according to DSM-IV criteria for major depressive disorder and comorbid status. Unit costs were attached to self-reported days absent from work and uptake of health care services. RESULTS: Medical comorbidity was associated with a 17-46% increase in health care costs in five of the six sites, but a clear positive association between costs and clinical depression status was identified in only one site. CONCLUSIONS: The economic consequences of depression are influenced to a greater (and considerable) extent by the presence of medical comorbidity than by symptom severity alone.
BACKGROUND: Despite the burden of depression, there remain few data on its economic consequences in an international context. AIMS: To explore the relationship between depression status (with and without medical comorbidity), work loss and health care costs, using cross-sectional data from a multi-national study of depression in primary care. METHOD: Primary care attendees were screened for depression. Those meeting eligibility criteria were categorised according to DSM-IV criteria for major depressive disorder and comorbid status. Unit costs were attached to self-reported days absent from work and uptake of health care services. RESULTS: Medical comorbidity was associated with a 17-46% increase in health care costs in five of the six sites, but a clear positive association between costs and clinical depression status was identified in only one site. CONCLUSIONS: The economic consequences of depression are influenced to a greater (and considerable) extent by the presence of medical comorbidity than by symptom severity alone.
Authors: A Carlo Altamura; Marta Serati; Alessandra Albano; Riccardo A Paoli; Ira D Glick; Bernardo Dell'Osso Journal: Eur Arch Psychiatry Clin Neurosci Date: 2011-02-18 Impact factor: 5.270
Authors: Javier García-Campayo; José Luis Ayuso-Mateos; Luis Caballero; Irene Romera; Enric Aragonés; Fernando Rodríguez-Artalejo; Deborah Quail; Inmaculada Gilaberte Journal: Prim Care Companion J Clin Psychiatry Date: 2008
Authors: Christopher Dowrick; C Shiels; H Page; J L Ayuso-Mateos; P Casey; O S Dalgard; G Dunn; V Lehtinen; P Salmon; M Whitehead Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2009-12-25 Impact factor: 4.328
Authors: Graham Thornicroft; Somnath Chatterji; Sara Evans-Lacko; Michael Gruber; Nancy Sampson; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Jordi Alonso; Laura Andrade; Guilherme Borges; Ronny Bruffaerts; Brendan Bunting; Jose Miguel Caldas de Almeida; Silvia Florescu; Giovanni de Girolamo; Oye Gureje; Josep Maria Haro; Yanling He; Hristo Hinkov; Elie Karam; Norito Kawakami; Sing Lee; Fernando Navarro-Mateu; Marina Piazza; Jose Posada-Villa; Yolanda Torres de Galvis; Ronald C Kessler Journal: Br J Psychiatry Date: 2016-12-01 Impact factor: 9.319
Authors: Sylke Andreas; Martin Härter; Jana Volkert; Maria Hausberg; Susanne Sehner; Karl Wegscheider; Sven Rabung; Berta Ausín; Alessandra Canuto; Chiara Da Ronch; Luigi Grassi; Yael Hershkovitz; Paul Lelliott; Manuel Muñoz; Alan Quirk; Ora Rotenstein; Ana Belén Santos-Olmo; Arieh Shalev; Jens Siegert; Kerstin Weber; Hans-Ulrich Wittchen; Uwe Koch; Holger Schulz Journal: BMC Psychiatry Date: 2013-02-18 Impact factor: 3.630